Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,985 | -28,388 | -14,308 | -53,472 | -38,388 |
| Depreciation Amortization | 335 | 194 | 26 | -253 | -35 |
| Accounts receivable | N/A | N/A | N/A | 12 | 12 |
| Accounts payable and accrued liabilities | -169 | 511 | 117 | -1,107 | -1,278 |
| Other Working Capital | -2,617 | -1,960 | -2,684 | -975 | -2,858 |
| Other Operating Activity | 4,947 | 2,626 | 1,357 | 6,826 | 5,353 |
| Operating Cash Flow | $-40,489 | $-27,017 | $-15,491 | $-48,969 | $-37,193 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,430 | 26,430 | 21,430 | 52,300 | 33,250 |
| PPE Investments | -76 | -70 | -38 | -343 | -172 |
| Purchase Of Investment | -5,410 | N/A | N/A | -44,661 | -28,915 |
| Investing Cash Flow | $20,944 | $26,360 | $21,393 | $7,297 | $4,164 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,345 | 980 | 980 | 28,645 | 28,637 |
| Other Financing Activity | 0 | 0 | 0 | -204 | -204 |
| Financing Cash Flow | $5,345 | $980 | $980 | $28,441 | $28,433 |
| Beginning Cash Position | 59,406 | 59,406 | 59,406 | 72,637 | 72,637 |
| End Cash Position | 45,206 | 59,729 | 66,287 | 59,406 | 68,040 |
| Net Cash Flow | $-14,200 | $323 | $6,881 | $-13,231 | $-4,597 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,489 | -27,017 | -15,491 | -48,969 | -37,193 |
| Capital Expenditure | -76 | -70 | -38 | -343 | -172 |
| Free Cash Flow | -40,565 | -27,087 | -15,529 | -49,311 | -37,365 |